(Q40607751)

22 September 2017

Increased transcriptional activity of the CYP3A4*1B promoter variant (English)

1 reference

22 September 2017

Amirimani B

1

1 reference

22 September 2017

Ning B

2

1 reference

22 September 2017

Deitz AC

3

1 reference

22 September 2017

Weber BL

4

1 reference

22 September 2017

Kadlubar FF

5

1 reference

22 September 2017

Rebbeck TR

6

1 reference

22 September 2017

1 January 2003

1 reference

Environmental and Molecular Mutagenesis

22 September 2017

1 reference

22 September 2017

42

1 reference

22 September 2017

299-305

1 reference

22 September 2017

4

1 reference

RESPONSE: re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

22 September 2017

1 reference

7 January 2021

Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

1 reference

7 January 2021

Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4

1 reference

7 January 2021

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

1 reference

7 January 2021

A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles

1 reference

7 January 2021

Association of CYP3A4 genotype with treatment-related leukemia

1 reference

7 January 2021

Genotype???phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women

1 reference

7 January 2021

Pharmacogenetic phenotyping and genotyping. Present status and future potential.

1 reference

7 January 2021

Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control.

1 reference

7 January 2021

CYP gene polymorphisms and early menarche

1 reference

7 January 2021

Common allelic variants of cytochrome P4503A4 and their prevalence in different populations

1 reference

7 January 2021

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions

1 reference

7 January 2021

Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.

1 reference

7 January 2021

The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer

1 reference

7 January 2021

Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5'-upstream regulatory region

1 reference

7 January 2021

Identifiers

DOI

10.1002/EM.10199

1 reference

22 September 2017

1 reference